According to Fox News, @realDonaldTrump announced plans to sign an executive order on Monday aimed at reducing the cost of prescription drugs and pharmaceuticals (source: Fox News, May 12, 2025). This move is expected to pressure pharmaceutical stock prices, potentially increasing volatility in related equities. Historically, regulatory actions in the healthcare sector have triggered capital shifts into alternative assets, including major cryptocurrencies like Bitcoin and Ethereum, as investors seek diversification (source: CoinDesk, historical trends). Traders should monitor both pharmaceutical equities and crypto market movements for near-term volatility and hedging opportunities.